About Us

Particella, Inc. (formerly DNAlite Therapeutics) is an early-stage preclinical biotechnology company committed to creating a category of medicines overcoming constraints of current biological medicines.

ORAL and repeatable Administration

Powered by a proprietary vector technology, all of Particella’s medicines are designed to be oral and non-immunogenic; overcoming the shortcomings of current biologics.

Treating the Cause of GI diseaseS

Particella is modifying the GI tract to restore its abilities in patients with genetic diseases or with compromised mucosa.

Genetic medicineS

We are harnessing our vector technology to carry mRNA and other nucleic acids to the GI cells to fight intestinal and systemic diseases